9 Words From Moderna's CEO That Could Signal a Boost in Vaccine Orders

9 Words From Moderna's CEO That Could Signal a Boost in Vaccine Orders

Shares of vaccine leader Moderna (NASDAQ: MRNA) slipped in early November after the biotech cut this year's sales forecast. CEO Stéphane Bancel spoke with newspaper The Financial Times about today's coronavirus vaccines -- and the possibility of handling the omicron variant. Healthcare officials discovered the omicron variant a few weeks ago in South Africa.